Following the latest financial statement of Aurora Cannabis, several analysts have changed their target. Here are the main observations and new target prices. (See the reports for more information)
Cannacord analyst lower its target following a desapointing quarter of the company and the industry in general. The firm lowered its short-term revenue forecast as well as EBITDA.
FY2020 net income from $525 to $413
FY2020 EBITDA from $99 to $82
Cannacord analyst issues a SPECULATVE BUY recommendation with target price of $6.00 CAD from $8.00 (15 Nov.2019)
Jefferies continues to believe that Aurora is positioned to be a global leader in the industry despite the disapointing financial.
Jeffries analyst still issues a BUY recommendation with a target price of CAD $7.00 (Nov 15, 1919)
For Eight Capital also, the latest results are below expectations but the company has taken steps to improve their capital position and balance sheet.
For Eight Capital analyst it is a BUY recomandation with target of 8.00 CAD (15 Nov.2019)
Cantor Fitgerald upgraded Aurora to Overweight from Neutral following the latest financial results. The analyst thinks the company is in a better position than its peers and has made good decisions for the future.
Cantor Fitgerald analyst upgrade Aurora to Overweight from Neutral with a target price of 5.85 CAD from 5.10 (15 Nov.2019)
This article is written and published by The Cannabis Stock
Disclaimer : The Cannabis Stock wants to promote the cannabis market with the best publication on the market. The Cannabis Stock does not recommend selling or buying any of the company mentioned and is not responsible for any losses that may result.